SUTRO BIOPHARMA, INC. - 8-K Filing
Sutro Biopharma held its 2026 Annual Meeting of Stockholders on June 5, 2026. Three Class II directors were elected with vote tallies as follows: Jane Chung (11,355,214 shares for), Connie Matsui (9,734,802 shares for), and James Panek (9,706,422 shares for). Shareholders also ratified the appointment of Ernst & Young LLP as independent auditors with 13,893,289 votes in favor. Additionally, non-binding advisory approval was given to executive compensation with 11,329,946 shares voting 'for.' (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $STRO